While health authorities and mainstream media have ignored, if not outright opposed, the use of vitamin C and other supplements in the treatment of COVID-19, citing lack of clinical evidence, a landmark review recommends the use of vitamin C as an adjunctive therapy for respiratory infections, sepsis and COVID-19
According to the authors, “Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19”
Oral vitamin C at doses of 2 to 8 grams a day have been shown to reduce the incidence and duration of respiratory infections
Intravenous vitamin C at 6 to 24 grams a day has been shown to reduce mortality, ICU admission rates, hospital stays and time on mechanical ventilation in patients with severe respiratory infections
An international vitamin C campaign has been launched in response to the landmark review
Dr Mercola Landmark Publication on Vitamin C for COVID-19
3 thoughts on “Landmark Publication on Vitamin C for COVID-19”
Comments are closed.
Reblogged this on The Most Revolutionary Act and commented:
Intravenous vitamin C at 6 to 24 grams a day has been shown to reduce mortality, ICU admission rates, hospital stays and time on mechanical ventilation in patients with severe respiratory infections.
LikeLiked by 1 person
Can I reblog this, please?
LikeLike
Is there a reblog button on article? If not click on link to original..
LikeLike